Clinical Trials in Maryland

Showing 6141-6160 of 23,284 trials

Clinical Trial of Approaches to Prostate Cancer Surgery

NCT05155501

This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.

Prostate Cancer

Weill Medical College of Cornell University600 participantsStarted May 2023

Washington D.C., District of Columbia, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +2 more locations

COMPLETEDPhase 317 miles

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

NCT03080883

This randomized phase III trial studies the best dose of apixaban and how well it works in preventing secondary cancer related venous thrombosis in cancer patients who have completed anticoagulation therapy. Apixaban may help in prevention by blocking some of the enzymes needed for venous thrombosis.

Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more

Academic and Community Cancer Research United370 participantsStarted Jul 2017

Scottsdale, Arizona, United States • Washington D.C., District of Columbia, United States • Jacksonville, Florida, United States +29 more locations

Clinical Trial of Approaches to Prostate Cancer Surgery

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Find Trials by Condition in Maryland

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults With Cutaneous Sarcoidosis (BEACON)

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).

Engaging Patients to Promote Deprescribing

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

RecruitmEnt Assessed by eleCtRical Impedance Tomography

BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

Digital Support Systems to Improve Child Health and Development in Peru